Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

Chiara Cantò, Hematologist in training, MD, Elena Ranucci, Pharmacist, Stefano Pulini, MD, Fiorenzo Santoleri, Pharmacist, Anna Maria Morelli, MD, Francesca Fioritoni, MD, Simona Falorio, MD, Lorenza Torti, PhD MD, Antonio Spadano, MD, Marianna D'Aloisio, MD, Mauro Di Ianni, MD PhD, Stella Santarone, MD, Paolo Di Bartolomeo, MD

Blood (2018) 132 (Supplement 1): 5653.

https://doi.org/10.1182/blood-2018-99-112595

Published: 2018

Journal Articles

Lenalidomide in Combination with Bendamustine for Patients with Chemorefractory Hodgkin Lymphoma: Final Results of the Leben Multicenter Phase 1/2 Study

Antonello Pinto, MD, Vincenzo Pavone, MD, Francesco Angrilli, MD, Mariangela Saggese, PharmD, Stefania Crisci, ScD, Caterina Patti, MD, Pier Luigi Zinzani, MD PhD, Alfonso Maria D'Arco, MD, Elena Cavalieri, MD, Attilio Guarini, MD, Michele Spina, MD, Daniela Carlino, MD, Simona Falorio, MD, Emanuela Morelli, MD, Manuela Arcamone, MD, Ferdinando Frigeri, MD PhD, Annarosaria De Chiara, MD, Rosaria De Filippi, MD PhD, Gaetano Corazzelli, MD

Blood (2015) 126 (23): 1541.

https://doi.org/10.1182/blood.V126.23.1541.1541

Published: 2015

Journal Articles

Risk and Response Adapted Treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL): Single Institutional Experience

Simona Falorio, MD, Francesco Angrilli, MD, Francesca Fioritoni, MD, Stella Santarone, MD, Giuseppe Fioritoni

Blood (2008) 112 (11): 4938.

https://doi.org/10.1182/blood.V112.11.4938.4938

Published: 2008

Journal Articles

Outcome of Refractory or Relapsed Patients after Front-Line Treatment for Hodgkin Lymphoma (HL): Experience of a Single Institution

Francesca Fioritoni, MD, Francesco Angrilli, MD, Simona Falorio, MD, Stella Santarone, MD, Giuseppe Fioritoni

Blood (2008) 112 (11): 4959.

https://doi.org/10.1182/blood.V112.11.4959.4959

Published: 2008

Journal Articles

Composite Lymphoma: A Late Relapsing Primary Cutaneous B Cell Lymphoma Coexisting with Nodal Hodgkin’s Lymphoma.

Stefano Pulini, MD, Francesco Angrilli, MD, Simona Falorio, MD, Giuseppe Fioritoni, MD

Blood (2007) 110 (11): 4426.

https://doi.org/10.1182/blood.V110.11.4426.4426

Published: 2007

NARROW

Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

Lenalidomide in Combination with Bendamustine for Patients with Chemorefractory Hodgkin Lymphoma: Final Results of the Leben Multicenter Phase 1/2 Study

Risk and Response Adapted Treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL): Single Institutional Experience

Outcome of Refractory or Relapsed Patients after Front-Line Treatment for Hodgkin Lymphoma (HL): Experience of a Single Institution

Composite Lymphoma: A Late Relapsing Primary Cutaneous B Cell Lymphoma Coexisting with Nodal Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

Lenalidomide in Combination with Bendamustine for Patients with Chemorefractory Hodgkin Lymphoma: Final Results of the Leben Multicenter Phase 1/2 Study

Risk and Response Adapted Treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL): Single Institutional Experience

Outcome of Refractory or Relapsed Patients after Front-Line Treatment for Hodgkin Lymphoma (HL): Experience of a Single Institution

Composite Lymphoma: A Late Relapsing Primary Cutaneous B Cell Lymphoma Coexisting with Nodal Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only